ClinVar Miner

Submissions for variant NM_001276345.2(TNNT2):c.720-13_720-11del

gnomAD frequency: 0.00031  dbSNP: rs397516480
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000036611 SCV000060266 uncertain significance not specified 2011-10-14 criteria provided, single submitter clinical testing The 690-13_690-11delCTT variant has not been previously reported nor previously identified by our laboratory. This variant is located in the 3' splice region b ut does not affect the highly conserved -1 and -2 positions. Positions -3 and - 5 to -12 are part of the splicing consensus sequence and variants involving thes e positions can sometimes affect splicing.
GeneDx RCV000036611 SCV000565618 likely benign not specified 2016-02-25 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Color Diagnostics, LLC DBA Color Health RCV001189709 SCV001357059 likely benign Cardiomyopathy 2019-03-19 criteria provided, single submitter clinical testing
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV001811246 SCV001470941 uncertain significance not provided 2019-11-11 criteria provided, single submitter clinical testing The TNNT2 c.690-13_690-11delCTT variant (rs397516480), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 43663). This variant is found in the African population with an allele frequency of 0.10% (25/24942 alleles) in the Genome Aggregation Database. This is an intronic variant that deletes 3 nucleotides, and computational analyses (Alamut v.2.11) predict that this variant may impact splicing by weakening the nearby canonical acceptor splice site. Due to limited information, the clinical significance of the c.690-13_690-11delCTT variant is uncertain at this time.
Invitae RCV002054593 SCV002357416 benign Hypertrophic cardiomyopathy 2; Dilated cardiomyopathy 1D; Cardiomyopathy, familial restrictive, 3 2023-12-28 criteria provided, single submitter clinical testing
All of Us Research Program, National Institutes of Health RCV001189709 SCV004818614 likely benign Cardiomyopathy 2023-12-18 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.